Thioredoxin-interacting protein promotes high-glucose-induced macrovascular endothelial dysfunction

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Research

Background:

• Thioredoxin-interacting protein (TXNIP) is a key regulator of glucose homeostasis, often dysregulated in diabetes.
• Endothelial dysfunction is an early indicator of cardiovascular disease (CVD) and a significant complication of diabetes.

Purpose of the Study:

• To investigate the role of TXNIP in endothelial dysfunction associated with Type 1 diabetes mellitus (T1D).
• To explore TXNIP as a potential biomarker for vascular complications in T1D.

Main Methods:

• Utilized a T1D-like rat model to assess TXNIP expression and markers of endothelial dysfunction.
• Employed primary human aortic endothelial cells (HAECs) to study the effects of TXNIP overexpression under high glucose conditions or via ChREBP induction.

Main Results:

• Diabetic rats exhibited elevated TXNIP mRNA and protein levels in peripheral blood compared to controls.
• Diabetic endothelium showed reduced nitric oxide (NO) and vascular endothelial growth factor (VEGF) production, alongside increased reactive oxygen species (ROS) and vascular cell adhesion molecule 1 (VCAM-1).
• TXNIP overexpression in HAECs led to increased apoptosis and impaired NO bioactivity.

Conclusions:

• TXNIP expression is significantly increased in a T1D model and is associated with endothelial dysfunction.
• TXNIP may play a causal role in promoting vascular complications in T1D.
• TXNIP warrants further investigation as a potential biomarker for vascular disease in T1D patients.